Description
This
Medical Association and Royal Pharmaceutical Society of Great Britain
source of information, British National Formulary 67 (March 2014), is
developed by MedHand Mobile Libraries. Improve your performance with
relevant, valid material which is accessed quickly and with minimal
effort in the palm of your hand using MedHand’s patented technology.Important:
This application is downloaded on your device and it securely enables
instant and uninterrupted access wherever you are as it does not rely on
a network connection while in use. The application is a single edition
only; to stay updated it is recommended to purchase the forthcoming
editions as they are revised twice yearly.
The British National Formulary (BNF) provides up-to-date, practical guidance on prescribing, dispensing, and administering medicines. This essential reference reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.
Content of the BNF reflects current best practice as well as legal and professional guidelines relating to the uses of medicines. The resource includes:
• Guidance on the drug management of common conditions
• Details of medicines prescribed within the UK with special reference to their uses, cautions, contra-indications, side-effects, doses and relative costs. This allows treatment to be tailored to the individual needs of each patient
• Guidance on prescribing, monitoring, dispensing and adminstering medicines.
The content is updated every 6 months, making it an up-to-date source of prescribing advice for informed decision-making.
BNF 67 (March 2014) has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice. Access to the latest edition of the BNF is vital for healthcare professionals, as there are a large number of updates from one edition to the next.
Some of the significant changes in this edition include:
• Updated advice on the withdrawal of benzodiazepines
• New MHRA advice on the safety of Metoclopramide – risk of neurological adverse effects
• Antiepileptic drugs - new advice on switching between different manufacturers’ products for a particular drug
• Update on malaria prophylaxis recommendations for specific countries
• Influenza vaccines - extension of childhood seasonal influenza vaccine programme
• Addition of varicella-zoster vaccine to immunisation schedule
The BNF evaluates clinical evidence from diverse sources with information validated by a network of clinical experts and published under the authority of a Joint Formulary Committee
Authors: British Medical Association and Royal Pharmaceutical Society of Great Britain
Download Link:
Mediafire
The British National Formulary (BNF) provides up-to-date, practical guidance on prescribing, dispensing, and administering medicines. This essential reference reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.
Content of the BNF reflects current best practice as well as legal and professional guidelines relating to the uses of medicines. The resource includes:
• Guidance on the drug management of common conditions
• Details of medicines prescribed within the UK with special reference to their uses, cautions, contra-indications, side-effects, doses and relative costs. This allows treatment to be tailored to the individual needs of each patient
• Guidance on prescribing, monitoring, dispensing and adminstering medicines.
The content is updated every 6 months, making it an up-to-date source of prescribing advice for informed decision-making.
BNF 67 (March 2014) has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice. Access to the latest edition of the BNF is vital for healthcare professionals, as there are a large number of updates from one edition to the next.
Some of the significant changes in this edition include:
• Updated advice on the withdrawal of benzodiazepines
• New MHRA advice on the safety of Metoclopramide – risk of neurological adverse effects
• Antiepileptic drugs - new advice on switching between different manufacturers’ products for a particular drug
• Update on malaria prophylaxis recommendations for specific countries
• Influenza vaccines - extension of childhood seasonal influenza vaccine programme
• Addition of varicella-zoster vaccine to immunisation schedule
The BNF evaluates clinical evidence from diverse sources with information validated by a network of clinical experts and published under the authority of a Joint Formulary Committee
Authors: British Medical Association and Royal Pharmaceutical Society of Great Britain
Download Link:
Mediafire
